For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Praxis Precision Medicines Inc (NASDAQ: PRAX) was $51.09 for the day, down -5.55% from the previous closing price of $54.09. In other words, the price has decreased by -$5.55 from its previous closing price. On the day, 1.79 million shares were traded. PRAX stock price reached its highest trading level at $52.65 during the session, while it also had its lowest trading level at $45.48.
Ratios:
Our analysis of PRAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.44 and its Current Ratio is at 8.44. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 07, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $80.
H.C. Wainwright reiterated its Buy rating for the stock on March 03, 2025, while the target price for the stock was revised from $120 to $105.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 14 ’24 when Nemiroff Alex sold 8,239 shares for $80.20 per share. The transaction valued at 660,827 led to the insider holds 10,301 shares of the business.
Mastrocola Lauren sold 5,188 shares of PRAX for $424,318 on Nov 14 ’24. The Principal Accounting Officer now owns 5,613 shares after completing the transaction at $81.78 per share. On Nov 14 ’24, another insider, Mastrocola Lauren, who serves as the Officer of the company, bought 5,189 shares for $81.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 1075229952 and an Enterprise Value of 774833216. For the stock, the TTM Price-to-Sale (P/S) ratio is 128.16 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 95.399 whereas that against EBITDA is -3.33.
Stock Price History:
The Beta on a monthly basis for PRAX is 2.62, which has changed by -0.074288845 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, PRAX has reached a high of $91.83, while it has fallen to a 52-week low of $26.70. The 50-Day Moving Average of the stock is 8.62%, while the 200-Day Moving Average is calculated to be -10.08%.
Shares Statistics:
PRAX traded an average of 362.76K shares per day over the past three months and 635860 shares per day over the past ten days. A total of 20.34M shares are outstanding, with a floating share count of 18.22M. Insiders hold about 10.57% of the company’s shares, while institutions hold 113.34% stake in the company. Shares short for PRAX as of 1752537600 were 1941375 with a Short Ratio of 5.35, compared to 1749772800 on 1742912. Therefore, it implies a Short% of Shares Outstanding of 1941375 and a Short% of Float of 9.55.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Praxis Precision Medicines Inc (PRAX) involves the perspectives of 6.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$3.29, with high estimates of -$2.97 and low estimates of -$3.82.
Analysts are recommending an EPS of between -$12.75 and -$14.03 for the fiscal current year, implying an average EPS of -$13.23. EPS for the following year is -$12.81, with 10.0 analysts recommending between -$3.7 and -$19.37.
